Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides
Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides
复制标题
DOI:
10.1016/j.euroneuro.2018.12.013
复制
发表时间:
2019-03-01
影响因子:
5.6
通讯作者:
van Rijn, Richard M.
中科院分区:
文献类型:
--
作者:
Cassell, Robert J.;Mores, Kendall L.;van Rijn, Richard M.
The impact that beta-arrestin proteins have on G protein-coupled receptor trafficking, signaling and physiological behavior has gained much appreciation over the past decade. A number of studies have attributed the side effects associated with the use of naturally occurring and synthetic opioids, such as respiratory depression and constipation, to excessive recruitment of beta-arrestin. These findings have led to the development of biased opioid small molecule agonists that do not recruit beta-arrestin, activating only the canonical G protein pathway. Similar G protein-biased small molecule opioids have been found to occur in nature, particularly within kratom, and opioids within salvia have served as a template for the synthesis of other G proteinbiased opioids. Here, we present the first report of naturally occurring peptides that selectively activate G protein signaling pathways at dopioid receptors, but with minimal beta-arrestin recruitment. Specifically, we find that rubiscolin peptides, which are produced as cleavage products of the plant protein rubisco, bind to and activate G protein signaling at dopioid receptors. However, unlike the naturally occurring dopioid peptides leu-enkephalin and deltorphin II, the rubiscolin peptides only very weakly recruit beta-arrestin 2 and have undetectable recruitment of beta-arrestin 1 at the d opioid receptor. (c) 2018 Elsevier B. V. and ECNP. All rights reserved.